Pravin R Chaturvedi is Chief Scientific Officer of Jaguar Health, Inc.. Currently has a direct ownership of 4,957 shares of JAGX, which is worth approximately $5,254. The most recent transaction as insider was on Oct 08, 2024, when has been sold 4,922 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.96K
131.53% 3M change
97.59% 12M change
Total Value Held $5,254

Pravin R Chaturvedi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 08 2024
BUY
Grant, award, or other acquisition
-
4,922 Added 49.82%
4,957 Common Stock
May 17 2024
BUY
Exercise of conversion of derivative security
-
871 Added 28.92%
2,141 Common Stock
Apr 05 2024
BUY
Exercise of conversion of derivative security
-
134 Added 9.54%
1,270 Common Stock
Aug 14 2023
BUY
Grant, award, or other acquisition
-
204,192 Added 49.86%
205,328 Common Stock
May 17 2023
BUY
Exercise of conversion of derivative security
-
870 Added 43.37%
1,136 Common Stock
Apr 05 2023
BUY
Exercise of conversion of derivative security
-
44 Added 33.33%
88 Common Stock
Apr 05 2022
BUY
Exercise of conversion of derivative security
-
3,333 Added 50.0%
3,333 Common Stock
PRC

Pravin R Chaturvedi

Chief Scientific Officer
San Francisco, CA

Track Institutional and Insider Activities on JAGX

Follow Jaguar Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAGX shares.

Notify only if

Insider Trading

Get notified when an Jaguar Health, Inc. insider buys or sells JAGX shares.

Notify only if

News

Receive news related to Jaguar Health, Inc.

Track Activities on JAGX